BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $171.16 million versus the consensus estimate of $160.8 million.

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.